Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Peter

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Immunotherapy|October 8, 2014
Immunoglobulin replacement therapy for primary immunodeficienciesJonathan G Peter, Helen Chapel
Plos One|February 8, 2013
Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?Jonathan G Peter, Grant Theron, Keertan Dheda
The Lancet. Infectious Diseases|October 27, 2012
Urine antigen test for diagnosis of HIV-associated tuberculosisJonathan G Peter, Grant Theron, Keertan Dheda
Circulation|March 11, 2024
Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?Jonathan G Peter, Ntobeko A B Ntusi, Mpiko Ntsekhe
The European Respiratory Journal|March 23, 2013
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settingsJonathan G Peter, Grant Theron, Nevanda Singh, et al.
Plos One|July 21, 2012
The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceJonathan G Peter, Grant Theron, Tapuwa E Muchinga, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2018
Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trialPoobalan Naidoo, Aliasgar Esmail, Jonathan G Peter, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trialJonathan G Peter, Grant Theron, Anil Pooran, et al.
European Journal of Medical Research|January 30, 2024
Comment on: Proposal for a new diagnostic classification of photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysisBukiwe N Thwala, Nadine Teixeira, Eddy Zitha, et al.
BMC Infectious Diseases|September 6, 2013
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studiesStephen D Lawn, Keertan Dheda, Andrew D Kerkhoff, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunotherapy|October 8, 2014
Immunoglobulin replacement therapy for primary immunodeficienciesJonathan G Peter, Helen Chapel
Plos One|February 8, 2013
Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?Jonathan G Peter, Grant Theron, Keertan Dheda
The Lancet. Infectious Diseases|October 27, 2012
Urine antigen test for diagnosis of HIV-associated tuberculosisJonathan G Peter, Grant Theron, Keertan Dheda
Circulation|March 11, 2024
Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?Jonathan G Peter, Ntobeko A B Ntusi, Mpiko Ntsekhe
The European Respiratory Journal|March 23, 2013
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settingsJonathan G Peter, Grant Theron, Nevanda Singh, et al.
Plos One|July 21, 2012
The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceJonathan G Peter, Grant Theron, Tapuwa E Muchinga, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2018
Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trialPoobalan Naidoo, Aliasgar Esmail, Jonathan G Peter, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trialJonathan G Peter, Grant Theron, Anil Pooran, et al.
European Journal of Medical Research|January 30, 2024
Comment on: Proposal for a new diagnostic classification of photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysisBukiwe N Thwala, Nadine Teixeira, Eddy Zitha, et al.
BMC Infectious Diseases|September 6, 2013
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studiesStephen D Lawn, Keertan Dheda, Andrew D Kerkhoff, et al.
Pageof 2